Diabetes News Archive

SILVER SPRING, Md., Jan. 25 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.

New research that significantly improves our understanding of how insulin interacts with cells in the human body is published today.The study could have major implications for the development of treatments for Type I diabetes.By developing and analysing a range of super active insulins,

( University of York ) New research significantly improves our understanding of how insulin interacts with cells in the human body with implications for the treatments of diabetes.

'Understanding Diabetes' lecture at Columbia Hospital

If you have diabetes you may also feel sad, hopeless or overwhelmed. It's normal to struggle with your emotions after a diagnosis of diabetes. But if the feelings linger or are severe, you could have depression.

Depression is common if you have diabetes. But, the two can be a dangerous mix. Find out how depression can be treated.

Thousands of children and teenagers with diabetes in the UK are left disenfranchised and at risk of developing serious health complications, because they feel healthcare professionals and schools don't always listen to their needs and help them control their diabetes. This is the finding of a report by Diabetes UK. We are now calling for improved provision of and access to educational and ...

DUBLIN----Research and Markets has announced the addition of GlobalData's new report "Type 1 Diabetes - Drug Pipeline Analysis and Market Forecasts to 2016" to their offering.

(PhysOrg.com) -- New UCL research shows that genetic testing provides no real help in predicting the risk of developing type 2 diabetes, a major risk factor for heart disease.

LONDON----People with diabetes or who are at risk of developing the disease - now estimated at over 400 million globally - could reduce complications, improve quality of life and reduce healthcare costs by using new non-invasive technology to screen for and monitor the illness, according to a presentation by Freedom Meditech at the 6th Annual Diabetes and Diabetic Retinopathy Conference in ...

COLUMBIA, Md.----Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell therapy, as a treatment for patients recently diagnosed with type 1 diabetes.

TORONTO -- Transition Therapeutics Inc. today announced the results from a Phase 2 clinical study of gastrin analogue, TT-223, in patients with type 2 diabetes.Patients who received the highest daily dose of TT-223 for 12 weeks and completed the entire study without adjusting their diabetes therapies experienced a statistically significant reduction in HbA1c of 1.13%, 6 months after completing ...

Party rolls toward cure for diabetes

Israel Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 is an essential source for in-depth information and data relating to Israel diabetes care devices market.

Netherlands Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 is an essential source for in-depth information and data relating to Netherlands diabetes care devices market.

Belgium Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 is an essential source for in-depth information and data relating to Belgium diabetes care devices market.

Republic of Korea Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 is an essential source for in-depth information and data relating to Republic of Korea diabetes care devices market.

Doctor's Diary: Why many of those diagnosed with diabetes may not have it at all.

The Wellness Initiative for Senior Education (WISE) Program celebrates healthy aging and educates older adults on a variety of topics.

Britain's soaring obesity rate has triggered record levels of the condition, which can result in blindness, nerve damage and amputations.